Did not become law. It stopped in the Senate's Banking & Insurance Committee on April 20, 2021. The 2021–2022 session has ended.
2021–2022 Regular Session
Senate Bill 579
An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; and establishing the Pharmaceutical Transparency Review Fund.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Its course
April 20 to April 20, 2021, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the SenateApr 20 to Apr 20 · stopped0 days
Banking & InsuranceApr 20 to Apr 20 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Apr 20
- Apr 20Sent to BANKING AND INSURANCE
All 1 actions, as published
- Apr 20Referred to BANKING AND INSURANCE, April 20, 2021 [Senate]Senate